Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Ganglioside GM1

Generic Name: Ganglioside GM1

Drug Type: Small Molecule

Chemical Formula: C_₇₃H_₁₃₁N_₃O_₃₁

CAS Number: 116950-37-9

Unique Ingredient Identifier: 562413257Z

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Phase 2

Recruiting

Posted: 2023/03/02

Sponsor:Alliance for Clinica...

ID:NCT05751668

GM1 Prophylaxis for WBRT Related Cognitive Dysfunction

Phase 3

Terminated

Posted: 2020/05/20

Sponsor:

Sun Yat-sen Universi...

ID:NCT04395339

Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer

Phase 3

Completed

Posted: 2014/09/29

Sponsor:

Yuhong Li

ID:NCT02251977

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Phase 2

Posted: 2014/03/21

Sponsor:

Sun Yat-sen Universi...

ID:NCT02093910

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC

Phase 3

Posted: 2013/12/31

Sponsor:Tianjin Medical Univ...

ID:NCT02024412

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy